Bio-FD&C Co

Bio-FD&C Co Equity Growth

The Year-over-Year Equity Growth of Bio-FD&C Co (251120.KQ) as of Nov 21, 2026 is 10.56 %. In the previous year, Year-over-Year Equity Growth was 7.70 % — a change of 37.10% (higher).

Equity Growth

10.56 %

YoY

37.10%

Last updated:

Year-over-Year Equity Growth of Bio-FD&C Co is 2025 10.56 % . Year-over-Year Equity Growth of Bio-FD&C Co was 2024 7.70 % . It decreases by 37.10% higher compared to the previous year.

The Bio-FD&C Co Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2019
34.61 KRW
Jan 1, 2020
24.71 KRW
Jan 1, 2021
27.83 KRW
Jan 1, 2022
233.55 KRW
Jan 1, 2023
10.65 KRW
Jan 1, 2024
7.70 KRW
Jan 1, 2025
10.56 KRW
The Bio-FD&C Co Equity Growth history
YEAREquity GrowthYoY
10.56 %+37.10%
7.70 %-27.65%
10.65 %-95.44%
233.55 %+739.14%
27.83 %+12.66%
24.71 %-28.62%
34.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Year-over-Year Equity Growth of Bio-FD&C Co is 10.56 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Bio-FD&C Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Bio-FD&C Co

All Key Metrics — Bio-FD&C Co